Partnership Value

ProteoNic acknowledges the high value of carefully selected partnerships. Such partnerships involve a high degree of win-win objectives. ProteoNic seeks out collaborations whereby explicitly all parties involved gain from the combined effort both scientifically and commercially. This means that partnerships in various forms can be build on R&D collaboration, marketing, combining technologies and/or products or a combination of these.

ProteoNic has established partnerships with companies in the industrial enzyme and biopharmaceutical market as well as with R&D and academic institutions enabling ProteoNic to intensify its research activities, extend the track record of its expertise and technology while sharing its knowledge and technology with its partners.

Partners of ProteoNic:

  • Novozymes
  • Evaluation of UNic-FTeeTM for expression of industrial enzymes in Aspergillus Niger.
  • Genencor
  • Research agreement - investigating enzyme production in Genencor’s fungal expression platforms using the UNic™ Toolbox.
  • Chr. Hansen
  • Contract research agreement for construct and strain engineering and UNic™ technology implementation.
  • Oxford Expression Technologies
  • Partnership combining ProteoNic’s award winning UNic™ translation enhancement technology with OET’s flashBAC™ system to further enhance protein yields through the synergistic effect of these two technologies.
  • Mycobics
  • Application of UNic™ technology in Streptomyces for industrial enzyme expression.
  • PharmaCell
  • Application of UNic™ technology in mammalian host systems for increased pharmaceutical protein production yield.
  • ModiQuest Research
  • Application of UNic™ technology in CHO host system for commercial antibody expression en cell line development.
  • TNO
  • Application of UNic™ technology in CHO host system for commercial protein expression.

  • ProFibrix
  • Feasibility study of application of UNic™ technology in CHO manufacturing cell line for recombinant fibrinogen.
  • Artes Biotechnology
  • Application of UNic™ technology in proprietary Hansenula polymorpha for three commercial proteins (industrial).

R&D collaborations:

 

  • - 06.02.2012 -Meet us atRead more
  • - 28.09.2011 -ProteoNic announces closing of financing roundRead more
  • - 04.05.2011 -ProteoNic becomes member of the Kluyver Centre Industrial PlatformRead more